Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_3
2
18%
Ph not_applicable
8
73%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
2(20.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(5)
Terminated(1)
Other(5)

Detailed Status

Completed5
unknown5
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (20.0%)
N/A8 (80.0%)

Trials by Status

withdrawn19%
completed545%
unknown545%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11